tiprankstipranks
Livzon Pharmaceutical Group Inc Class H (HK:1513)
:1513
Hong Kong Market

Livzon Pharmaceutical Group (1513) Income Statement

Compare
0 Followers

Livzon Pharmaceutical Group Income Statement

Last quarter (Q3 2024), Livzon Pharmaceutical Group's total revenue was ¥2.80B, a decrease of -5.59% from the same quarter last year. In Q3, Livzon Pharmaceutical Group's net income was ¥501.76M. See Livzon Pharmaceutical Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 12.43B¥ 12.63B¥ 12.06B¥ 10.52B¥ 9.38B
Gross Profit
¥ 7.66B¥ 8.17B¥ 7.81B¥ 6.85B¥ 5.99B
Operating Expenses
¥ 5.24B¥ 5.93B¥ 5.62B¥ 4.53B¥ 4.41B
Depreciation and Amortization
¥ 840.32M¥ 652.32M¥ 445.27M¥ 394.30M¥ 384.61M
EBITDA
¥ 3.33B¥ 3.08B¥ 2.77B¥ 2.91B¥ 2.12B
Operating Income
¥ 2.42B¥ 2.35B¥ 2.27B¥ 2.50B¥ 1.73B
Other Income/Expenses
¥ -32.44M¥ -20.01M¥ -21.30M¥ -11.01M¥ -2.31M
Pretax Income
¥ 2.38B¥ 2.33B¥ 2.25B¥ 2.49B¥ 1.73B
Net Income
¥ 1.95B¥ 1.91B¥ 1.78B¥ 1.71B¥ 1.30B
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ 2.10¥ 2.04¥ 1.90¥ 1.83¥ 1.39
Diluted EPS
¥ 2.10¥ 2.04¥ 1.90¥ 1.83¥ 1.39
Weighted Average Shares Outstanding
930.31M 933.86M 934.46M 936.16M 934.76M
Weighted Average Shares Outstanding (Diluted)
930.61M 935.98M 934.57M 937.11M 937.32M
Currency in CNY

Livzon Pharmaceutical Group Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis